tiprankstipranks
Trending News
More News >
Healthcare Realty Trust (HR)
NYSE:HR

Healthcare Realty Trust (HR) AI Stock Analysis

Compare
614 Followers

Top Page

HR

Healthcare Realty Trust

(NYSE:HR)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 4o)
Rating:56Neutral
Price Target:
$17.50
▲(2.52% Upside)
Healthcare Realty Trust's overall stock score is driven by its mixed financial performance and bearish technical indicators. The earnings call provides a positive outlook with strong NOI growth and improved leverage, but ongoing profitability challenges and a high volume of asset dispositions weigh on the score. The attractive dividend yield offers some valuation support, but the negative P/E ratio reflects underlying financial difficulties.
Positive Factors
Strong Cash Flow Generation
The strong cash flow generation indicates efficient operations and provides the company with the flexibility to invest in growth opportunities and manage debt effectively.
Improved Occupancy Rates
Higher occupancy rates suggest improved demand for healthcare facilities, enhancing revenue stability and supporting long-term lease agreements.
Equity Program for Growth
The equity program provides capital for growth initiatives and debt repayment, strengthening the company's financial position and market competitiveness.
Negative Factors
Declining Revenue Trend
A declining revenue trend can hinder long-term growth prospects and indicates challenges in maintaining market share and competitive positioning.
High Asset Disposition Volume
Frequent asset sales may indicate underlying operational challenges and could disrupt revenue streams, impacting long-term stability.
Profitability Challenges
Ongoing profitability challenges can strain financial resources and limit the ability to reinvest in business growth and innovation.

Healthcare Realty Trust (HR) vs. SPDR S&P 500 ETF (SPY)

Healthcare Realty Trust Business Overview & Revenue Model

Company DescriptionHealthcare Realty Trust (HR) is a real estate investment trust (REIT) focused on acquiring, owning, and managing healthcare-related properties. Established to serve the growing demand for healthcare facilities, the company primarily invests in outpatient medical office buildings, inpatient rehabilitation facilities, and other healthcare properties located near or on hospital campuses. With a strategic emphasis on long-term leases and relationships with healthcare providers, HR aims to provide a stable income stream for its investors while supporting the healthcare sector's infrastructure needs.
How the Company Makes MoneyHealthcare Realty Trust generates revenue primarily through the leasing of its healthcare properties to medical providers and organizations. The company's revenue model is based on long-term lease agreements, often structured to provide predictable cash flows. Key revenue streams include rental income from tenants, which typically consists of base rent and, in some cases, additional charges for property-related expenses. The company also benefits from strategic partnerships with healthcare systems and providers, leading to increased occupancy rates and stable lease renewals. Furthermore, HR may engage in property acquisitions and developments that can enhance its portfolio, thereby contributing to revenue growth over time. Overall, the company's focus on the healthcare sector, combined with its real estate expertise, positions it to capitalize on the increasing demand for healthcare facilities and services.

Healthcare Realty Trust Earnings Call Summary

Earnings Call Date:Oct 30, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 04, 2026
Earnings Call Sentiment Positive
The earnings call reflects a positive outlook with strong NOI growth, improved occupancy rates, and significant asset dispositions. The company is effectively managing leverage and has capital to invest in growth opportunities. However, challenges remain in non-core markets, and the high volume of dispositions indicates ongoing restructuring efforts.
Q3-2025 Updates
Positive Updates
Strong Same-Store NOI Growth
Same-store NOI growth averaged 5.25% over the last two quarters, with a third-quarter growth of 5.4%.
Increased Occupancy Rates
Same-store occupancy increased by 180 basis points over the last two quarters, reaching 91.1%.
Improved Leverage
Net debt to adjusted EBITDA reduced by 0.5 turns, now below 6x, with a 5.8x ratio reported for the third quarter.
Successful Leasing Activity
Leasing activity included 1.6 million square feet of executed leases, with tenant retention reaching nearly 89%, the highest in six years.
Capital to Invest
For the first time in years, Healthcare Realty has capital available to invest accretively into the portfolio.
Pipeline of Dispositions
Year-to-date, $500 million of assets sold, with $700 million more under contract or LOI, expected to close soon.
Development and Redevelopment Progress
Active development projects in Fort Worth and Raleigh are progressing well, with stabilized NOI expected to be approximately $8 million.
Negative Updates
Disposition of Non-Core Assets
Non-core assets sold at a blended cap rate of 7.25%, reflecting suboptimal operating performance and significant capital needs.
Challenges in Certain Markets
Assets in non-priority markets and those with significant capital needs are being sold, indicating challenges in those areas.
High Asset Disposition Volume
The company is facing a high volume of asset sales, with over a dozen transactions required to achieve disposition goals.
Company Guidance
During Healthcare Realty's Third Quarter 2025 Earnings Conference Call, the company provided several key metrics and updates on their strategic initiatives. Over the last two quarters, Healthcare Realty achieved an average same-store NOI growth of 5.25% and increased same-store occupancy by 180 basis points. The company's net debt to EBITDA ratio was reduced by 0.5 turns, now standing below 6x for the first time since early 2022. They raised their FFO guidance, with normalized FFO reported at $0.41 per share. Healthcare Realty has a robust leasing pipeline of 1.1 million square feet, with 2/3 in the LOI or lease documentation phase. They completed $500 million in asset sales at a 6.5% cap rate year-to-date and have a remaining disposition pipeline of approximately $700 million, mostly under binding contract or LOI. The company is also focused on development and redevelopment projects, expecting $8 million stabilized NOI from current projects. Additionally, a new $1 billion ATM equity program and up to $500 million in share buybacks have been authorized.

Healthcare Realty Trust Financial Statement Overview

Summary
Healthcare Realty Trust exhibits a mixed financial performance. The income statement shows challenges with declining revenue and profitability, but the balance sheet is stable with low leverage. The cash flow statement is a bright spot, showing strong cash generation and growth. The company needs to address profitability issues to improve overall financial health.
Income Statement
45
Neutral
Healthcare Realty Trust's income statement shows a declining revenue trend with a negative revenue growth rate of -2.33% in the TTM. The company is struggling with profitability, as indicated by a negative net profit margin of -26.44% and a negative EBIT margin. However, the gross profit margin remains relatively strong at 61.35%, suggesting some operational efficiency. The EBITDA margin is also robust at 58.32%, indicating good cash earnings potential despite net losses.
Balance Sheet
60
Neutral
The balance sheet reflects a strong equity position with a low debt-to-equity ratio of 0.05 in the TTM, indicating low leverage and financial stability. However, the return on equity is negative, reflecting ongoing net losses. The equity ratio is healthy, suggesting a solid asset base funded by equity. Overall, the balance sheet is stable but impacted by profitability challenges.
Cash Flow
70
Positive
Cash flow analysis reveals a significant improvement in free cash flow growth at 119.67% in the TTM, indicating enhanced cash generation capabilities. The operating cash flow to net income ratio is strong at 1.94, suggesting efficient cash conversion from operations. The free cash flow to net income ratio is also high, reflecting good cash flow relative to net losses. Overall, cash flow metrics are a positive aspect of the company's financials.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.18B1.25B1.33B918.93M524.53M499.63M
Gross Profit732.10M775.72M825.88M574.89M312.25M303.12M
EBITDA489.55M295.55M741.80M666.71M326.30M323.19M
Net Income-367.31M-654.49M-278.26M40.90M66.66M72.19M
Balance Sheet
Total Assets9.86B10.65B12.64B13.85B4.26B3.81B
Cash, Cash Equivalents and Short-Term Investments43.34M68.92M25.70M60.96M13.18M15.30M
Total Debt4.72B4.96B5.30B5.70B1.92B1.71B
Total Liabilities5.11B5.35B5.71B6.17B2.07B1.86B
Stockholders Equity4.68B5.23B6.82B7.57B2.19B1.95B
Cash Flow
Free Cash Flow219.16M252.64M268.79M109.20M131.94M376.13M
Operating Cash Flow462.77M501.62M499.82M272.75M232.63M470.09M
Investing Cash Flow603.00M900.92M349.14M1.63B-562.47M-555.17M
Financing Cash Flow-1.05B-1.36B-884.22M-1.86B327.72M99.72M

Healthcare Realty Trust Technical Analysis

Technical Analysis Sentiment
Negative
Last Price17.07
Price Trends
50DMA
17.81
Negative
100DMA
17.45
Negative
200DMA
16.26
Positive
Market Momentum
MACD
-0.22
Positive
RSI
38.47
Neutral
STOCH
15.62
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HR, the sentiment is Negative. The current price of 17.07 is below the 20-day moving average (MA) of 17.56, below the 50-day MA of 17.81, and above the 200-day MA of 16.26, indicating a neutral trend. The MACD of -0.22 indicates Positive momentum. The RSI at 38.47 is Neutral, neither overbought nor oversold. The STOCH value of 15.62 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HR.

Healthcare Realty Trust Risk Analysis

Healthcare Realty Trust disclosed 42 risk factors in its most recent earnings report. Healthcare Realty Trust reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Healthcare Realty Trust Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$8.11B27.088.13%3.56%59.25%88.37%
77
Outperform
$3.69B24.4510.87%4.67%8.04%9.20%
77
Outperform
$4.70B25.926.29%6.37%8.12%75.95%
70
Neutral
$1.64B47.243.49%6.63%11.89%-68.41%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
56
Neutral
$6.02B-16.13-7.26%6.44%-6.59%33.35%
55
Neutral
$2.95B-14.02%6.50%45.56%73.44%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HR
Healthcare Realty Trust
17.07
1.45
9.28%
LTC
LTC Properties
34.37
1.74
5.33%
NHI
National Health Investors
78.35
12.86
19.64%
SBRA
Sabra Healthcare REIT
18.84
2.95
18.57%
MPW
Medical Properties
5.08
1.56
44.32%
CTRE
CareTrust REIT
36.26
10.20
39.14%

Healthcare Realty Trust Corporate Events

Private Placements and FinancingBusiness Operations and Strategy
Healthcare Realty Trust Announces $1 Billion Equity Program
Positive
Dec 17, 2025

On December 17, 2025, Healthcare Realty Trust announced it entered equity distribution agreements and master forward confirmations with several financial firms for an equity offering program worth up to $1 billion. The move allows the company to issue Class A common stock and potentially engage in forward sale agreements to generate proceeds for general corporate purposes, including healthcare facility projects and debt repayment, reflecting a strategic step to secure capital for growth and strengthen its market positioning.

DividendsBusiness Operations and StrategyFinancial Disclosures
Healthcare Realty Trust Reports Q3 2025 Financial Results
Positive
Oct 30, 2025

Healthcare Realty Trust reported a GAAP net loss of $0.17 per share for the third quarter of 2025, with Normalized FFO of $0.41 per share and a same-store cash NOI growth of 5.4%, driven by increased occupancy and tenant retention. The company executed leases totaling 1.6 million square feet and completed asset sales worth $404 million, with additional sales under contract, reflecting strategic market exits and property monetizations. The company also advanced its development and redevelopment projects, enhancing its portfolio in key markets. The board approved a dividend of $0.24 per share, and the company increased its guidance for Normalized FFO per share and same-store cash NOI growth for 2025.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 19, 2025